The trademark #1A POLPHARMA was filed by SWISS PHARMA INTERNATIONAL AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on March 22, 2021, and received one opposition filed on June 22, 2021 by Novartis AG on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 22, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).